Champions Oncology released the figures for the annual quarter on the all-Drei Monats Finance Conference on the annual quarter expired on July 31, 2025.
1 Analyst estimates that Champions Oncology will report a loss per share of -0.010 USD for the recent quarter. In the previous year, the company generated an EPS of USD 0.090 per share.
1 Analyst expects sales of $ 13.5 million – that would be a discount of 3.91 percent compared to the previous year, in which $ 14.1 million had been implemented.
For the current fiscal year, 1 Analyst forecasts a profit per share of $ 0.220, compared to 0.330 in the previous year. The turnover is estimated from 1 analyst to $ 61.0 million after $ 56.9 million was generated in the previous year.
Editor finance.net
By the way: Champions Oncology and other US shares are even tradable at Finance.net Zero until 11 p.m. (without order fees, plus spreads). Open Depot now for free And secure new customer bonus!
Selected leverage products on Champions Oncology
With knock-outs, speculative investors can participate disproportionately in price movements. Simply choose the desired lever and we will show you suitable open-end products on Champions Oncology
The lever must be between 2 and 20
Advertising
